<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>
<head>
<title>6 cardiovascular - Sympathomimetics</title>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<link href="../sgStyles2.css" rel="stylesheet" type="text/css">
<link href="../favicon.png" rel="shortcut icon" />
<script type="text/javascript"><!--//--><![CDATA[//><!--

sfHover = function() {
	var sfEls = document.getElementById("nav").getElementsByTagName("LI");
	for (var i=0; i<sfEls.length; i++) {
		sfEls[i].onmouseover=function() {
			this.className+=" sfhover";
		}
		sfEls[i].onmouseout=function() {
			this.className=this.className.replace(new RegExp(" sfhover\\b"), "");
		}
	}
}
if (window.attachEvent) window.attachEvent("onload", sfHover);

//--><!]]></script>
</head>
<body>
<a id="top"></a>
<div id="bannerSG">
  <div class="indent120"><img src="../images/red-cattle.jpg" border="0" /></div>
</div>
<div id="text">
  <h1>Sympathomimetics</h1>
  <p><strong>sympathomimetic</strong> - a drug which mimics the effects of the sympathetic system. Modern drugs used for heart disease are all &#946;<sub>1</sub> agonists.</p>
  <p>These drugs may be used for short term inotropic support of a failing myocardium. They have a very short half life and therefore are only really useful as either an iv bolus or as constant rate infusions; ie in intensive care. They are therefore normally used only in acute heart failure. Traditionally, dobutamine has been used in dogs and horses, and dopamine in people, but there is no good reason for this. Adrenaline is cheap, and is the best drug to treat anaphylaxis in the field. This means that it should always be available and you must memorise the dose rate. Sympathomimetics are primarily used as inotropes, usually for their &#946;<sub>1</sub> agonist effects, but &#946;<sub>1</sub> receptor activation also increases automaticity of myocardial cells so ventricular ectopic beats are a common sign of overdose. These may progress to ventricular tachycardia or even ventricular fibrillation, so ECG monitoring is necessary. Since the object of therapy is to increase arterial blood pressure, this is usually monitored directly.</p>
  <p>Tolerance to &#946;<sub>1</sub> receptor activation can occur after as little 
    as 8 hours so long term use is usually limited to 3 days maximum.</p>
  <p>&#945;<sub>1</sub> receptor agonists produce vasocontriction, which can sometimes be useful, and sometimes dangerous. The vasoconstrictor effects of adrenaline are useful in anaphylaxis, but not usually in acute heart failure. Relatively selective  &#945;<sub>1</sub> agonists such as methoxamine or ephedrine are not used much these days (except in the <a href="../autonFiles/autonBladInc.html">bladder</a>): <a href="cardFlu.html">fluids</a> are usually used instead.</p>
  <table border="0" cellspacing="0" cellpadding="3">
    <tr class="tableTitle">
      <td>effect on</td>
      <td>rate</td>
      <td>force</td>
      <td>SVR</td>
      <td>ABP</td>
    </tr>
    <tr>
      <td>adrenaline</td>
      <td>++</td>
      <td>+++</td>
      <td>+++</td>
      <td>+++</td>
    </tr>
    <tr>
      <td>noradrenaline</td>
      <td>-</td>
      <td>0/+</td>
      <td>+++</td>
      <td>+++</td>
    </tr>
    <tr>
      <td>dopamine</td>
      <td>0</td>
      <td>+++</td>
      <td>0/-</td>
      <td>++</td>
    </tr>
    <tr>
      <td>isoprenaline</td>
      <td>+++</td>
      <td>+++</td>
      <td>-</td>
      <td>+/-</td>
    </tr>
    <tr>
      <td>dobutamine</td>
      <td>+</td>
      <td>+++</td>
      <td>+</td>
      <td>+++</td>
    </tr>
    <tr>
      <td>dopexamine</td>
      <td>0/+</td>
      <td>+++</td>
      <td>0</td>
      <td>+++</td>
    </tr>
  </table>
  <p>nb: different effects occur at different doses (SVR = systemic vascular resistance; ie, vasoconstriction: ABP = arterial blood pressure)</p>
  <h2>Drugs</h2>
  <p><strong>Adrenaline</strong> (epinephrine USAN) is an agonist at &#x03B2;<sub>1</sub> and &#x03B1;<sub>1</sub> receptors in the heart (positive inotrope and chronotrope) and all adrenergic receptors peripherally (predominantly arteriolar constriction and a subsequent increase in afterload).<br>
    Adrenaline usually comes as a 1:1000 solution in brown ampoules (it is light and oxygen sensitive), but it should be diluted to at least 1:10,000 before use. It can be mixed with most iv fluids for infusion.<br>
    <em>Indications</em></p>
  <ul>
    <li>cardiac arrest:<br>
      to increase the efficacy of electrical defibrillation<br>
      (asystole and severe bradyarrhythmias) use atropine first
    <li>inotropic infusion in intensive care (must monitor ECG)
    <li>anaphylaxis / analphylactoid reactions (often to drugs) - im or sc bolus injections usually used in the field
  </ul>
  <p><em>Side effects</em><br>
    tachyarrhythmias leading to ventricular ectopic beats and ultimately ventricular fibrillation in overdose - monitor ECG and feel pulse for irregularities. nb tachyarrhythmias are more likely in the presence of halothane.<br>
    <div id="drugbox">
    <p class="warning">Dose of adrenaline</p>
    <p>Dilute to 1:10,000 (100&micro;g/mL)<br>
    &#x2022; 20 &micro;g/kg im or<br>
    &#x2022; 5 - 20 &micro;g/kg iv or<br>
    &#x2022; 20&micro;g/kg intratracheal, or as a last resort only<br>
    &#x2022; 2 &micro;g/kg intracardiac (avoid if possible)</strong></p>
    <p>This may have to be given in an emergency - memorise the dose!</p></div>
  <p><strong>Noradrenaline</strong> (norepinephrine USAN) is mainly an &#945; agonist 
    (vasoconstriction) but has some useful &#946;<sub>1</sub> effects at higher 
    doses. It is indicated for haemostasis of mucosae and has been used for systemic 
    vasoconstriction. It is contraindicated in heart failure (increases afterload).</p>
  <p><strong>Isoprenaline</strong> (isoproterenol USAN) is a synthetic &#946;<sub>1</sub> and &#946;<sub>2</sub> receptor agonist which increases heart rate more than 
    other catecholamines. It decreases peripheral vascular resistance by its &#946;<sub>2</sub> effects. This may cause a decrease in blood pressure. It has no real place in 
    the treatment of heart failure as it has a positive chronotropic effect ie. 
    increase heart rate, and a potential to cause malignant ventricular dysrhythmias. 
    It is occasionally used to increase heart rate in third degree heart block (but 
    a pacemaker is better).</p>
  <p><strong>Dopamine</strong> is an endogenous precursor of noradrenaline but also 
    has direct effects. At a low dose (2&micro;g/kg/min) it is a dopamine receptor 
    agonist and causes renal, mesenteric, (coronary, cerebral) arteriolar vasodilatation. 
    At a medium dose (2 - 5&micro;g/kg/min) it acts at &#946;<sub>1</sub> receptors 
    to produce positive inotropy. At a slightly higher dose (5 - 10&micro;g/kg/min) 
    it acts at &#946;<sub>1</sub> receptors to cause positive chronotropy and increased 
    automaticity as well. At high doses (&gt;10&micro;g/kg/min) it affects &#945;<sub>1</sub> receptors, either directly or by causing the release of noradrenaline, and causes 
    vasoconstriction.<br>
    Since it must be given by infusion, dopamine is usually only used in intensive 
    care, as a positive inotrope in acute heart failure or in shock when renal and 
    mesenteric flow is decreased from vasoconstriction.<br>
    <em>Side effects</em> are dose dependent and include tachycardia, supraventricular 
    and / or ventricular arrhythmias, vomiting, hypotension, and vasoconstriction. 
    Since it is used by infusion and it has a very short half life treatment of 
    toxicity is by slowing or stopping it<br>
    <em>Contraindications</em> - ventricular fibrillation &amp; uncorrected arrhythmias<br>
    It is always given by infusion, starting at a low dose (1 &micro;g/kg/min). 
    Effects are monitored (ECG, ABP) and rate increased until the desired effect 
    has been reached or toxicity (tachycardia, ventricular ectopic beats) occurs. 
    Accurate control of infusion rate requires an infusion pump.</p>
  <p><strong>Dobutamine</strong> is a synthetic catecholamine with predominant &#946;<sub>1</sub> agonist effects which increase contractility and is relatively non-arrhythmic. 
    It favours cardiac output redistribution to coronary and skeletal muscle beds. 
    Renal and mesenteric flows also increase due to a total increase in cardiac 
    output. It enhances AV conduction resulting in mild positive chronotropic effect<br>
    It is used to increase contractility in patients in acute heart failure (horses 
    under anaesthesia), and for short term stabilisation of chronic heart failure 
    until longer acting drugs can take effect. <br>
    Side effects are similar to dopamine.</p>
  <p><strong>Dopexamine</strong> is similar to dopamine but longer acting. Not available 
    in NZ at present.</p>
  <h2>Do not use!</h2>
  <p>Since most inotropes act to increase intracellular calcium, it seems logical 
    to use calcium salts (gluconate / chloride) as inotropes. They can be effective 
    and used to be used for this purpose, especially after cardiac arrest, but they 
    are much better at causing contraction of smooth muscle than cardiac muscle. 
    This means that they produce intense vasoconstriction - in the coronary and 
    cerebral vessels this will potentiate or even cause ischaemia. Calcium has been 
    shown to reduce survival in acute heart failure and should not be used as an 
    inotrope. Indeed, modern practice is to use calcium channel blockers to cause 
    coronary and cerebral vasodilatation in cardiac intensive care, despite the 
    small reducution in cardiac output they cause.</p>
  <p><a href="../../lectureSite/PharmLec4/02SympIno.pdf">Sypathomimetic inotropes lecture</a></p>
  <p>
    <input type="Button" value="Previous Page" onClick="history.go(-1)">
  </p>
</div>
<div id="suckerfish">
  <!--Son of Suckerfish menu http://www.htmldog.com-->
  <ul id="nav">
    <li><a href="http://calve.massey.ac.nz/">CALVE</a> </li>
    <li><a href="/pharm/indexpharm.html">Home</a> </li>
    <li><a class="daddy" href="/pharm/indexpharm.html">Pharmacology</a>
      <ul>
        <li><a class="daddy" href="/pharm/pharmBits/adminfiles/adminIndex3.html">admin sem 1</a>
          <ul>
            <li><a href="/pharm/pharmBits/adminfiles/adminAss3.html">Exams</a> </li>
            <li><a href="/pharm/pharmBits/adminfiles/adminWGp3.html">Work groups info</a> </li>
          </ul>
        </li>
        <li><a href="/pharm/pharmBits/adminfiles/adminIndex3.html">admin sem 2</a> </li>
      </ul>
    </li>
    <li><a class="daddy" href="/pharm/toxSite/indexTox.html">Toxicology</a>
      <ul>
        <li><a class="daddy" href="/pharm/toxSite/poisonplants/index.html">Poisonous plants</a>
          <ul>
            <li><a href="/pharm/toxSite/poisonplants/comNames.html">Common names</a> </li>
            <li><a href="/pharm/toxSite/poisonplants/latNames.html">Latin names</a> </li>
            <li><a href="/pharm/toxSite/poisonplants/toxIndex.html">Plant toxins</a> </li>
          </ul>
        </li>
        <li><a href="/pharm/lectureSite/indexLec.html">Lectures</a> </li>
      </ul>
    </li>
    <li><a class="daddy" href="/pharm/studyGuideSite/indexSG.html">Study guide</a>
      <ul>
        <li><a href="/pharm/studyGuideSite/basicsFiles/basicsIndex.html">Basics</a> </li>
        <li><a href="/pharm/studyGuideSite/PKsFiles/PKsIndex.html">Pharmacokinetics</a> </li>
        <li><a href="/pharm/studyGuideSite/autonFiles/autonIndex.html">Autonomic system</a> </li>
        <li><a href="/pharm/studyGuideSite/CNSFiles/CNSIndex.html">CNS</a> </li>
        <li><a href="/pharm/studyGuideSite/cardioFiles/cardIndex.html">Cardiovascular system</a> </li>
        <li><a href="/pharm/studyGuideSite/InfHoFiles/InfHoIndex.html">Inflammation and Hormones</a> </li>
        <li><a href="/pharm/studyGuideSite/abFiles/abIndex.html">Antibiotics</a> </li>
        <li><a href="/pharm/studyGuideSite/skinFiles/skinIndex.html">Skin</a> </li>
        <li><a href="/pharm/studyGuideSite/lawFiles/lawIndex.html">Law</a> </li>
      </ul>
    </li>
    <li><a class="daddy" href="/pharm/lectureSite/indexLec.html">Lectures</a>
      <ul>
        <li><a href="/pharm/lectureSite/indexLec.html#sem1">Semester 1</a> </li>
        <li><a href="/pharm/lectureSite/indexLec.html#sem2">Smester 2</a> </li>
        <li><a href="/pharm/lectureSite/indexLec.html#nurses">Nurses</a> </li>
      </ul>
    </li>
    <li><a href="/pharm/formSite/Aform.html">Formulary</a> </li>
    <li><a href="/pharm/casesSite/indexCases.html">Cases</a> </li>
    <li><span id="small">links on this page</span> </li>
  </ul>
</div>
<div id="footer">
  <h2><a href="cardIndex.html">6 Cardiovascular index</a></h2>
  <div class="butNav"><a href="../../indexpharm.html"><img src="../../PharmBut.gif" height="21" border="0" /></a></div>
  <div class="butNav"><a href="../../toxSite/indexTox.html"><img src="../../ToxBut.gif" height="21" border="0" /></a></div>
  <div class="butNav"><a href="../indexSG.html"><img src="../../SGbut.gif" height="21" border="0" /></a></div>
  <div class="butNav"><a href="../../lectureSite/indexLec.html"><img src="../../LecBut.gif" height="21" border="0" /></a></div>
  <div class="butNav"><a href="../../formSite/Aform.html" target="_blank"><img src="../../FormBut.gif" height="21" border="0" /></a></div>
  <div class="butNav"> <a href="../../casesSite/indexCases.html"><img src="../../CaseBut.gif" height="21" border="0" /></a></div>
  <div id="logo">
    <div align="right">copyright Massey University</div>
  </div>
  <div id="gototop"><a href="#top"><b>top</b></a></div>
</div>
</body>
</html>
